ThursdayJul 02, 2026 12:35 pm

QualityStocksNewsBreaks – Frontieras North America Reopens Regulation A+ Offering at $9.01 Per Share 

Frontieras North America announced the reopening of its Regulation A+ public offering at $9.01 per share following SEC requalification after fully subscribing its initial offering at the $25.7 million qualified ceiling. The expanded offering, available through the DealMaker platform to accredited and non-accredited investors, follows the company's filing to increase the offering to the $75 million statutory maximum and reflects progress that includes the April groundbreaking of its planned $850 million commercial facility in Mason County, West Virginia. Frontieras said proceeds will support commercialization of its patented FASForm(TM) Solid Carbon Fractionation technology, which is designed to convert coal and other solid hydrocarbons into fuels, hydrogen and other industrial products without combustion. To…

Continue Reading

ThursdayJul 02, 2026 12:10 pm

QualityStocksNewsBreaks – Alpex Acquisition Corporation (NASDAQ: ALPXU) Closes $115 Million Initial Public Offering

Alpex Acquisition (NASDAQ: ALPXU) announced the closing of its initial public offering of 11.5 million units, including the full exercise of the underwriters' over-allotment option, generating gross proceeds of $115 million before expenses. The units began trading on the Nasdaq Global Market on June 25 under the ticker "ALPXU," with each unit consisting of one Class A ordinary share, one redeemable warrant and one right to receive one-fourth of one Class A ordinary share upon completion of an initial business combination. Concurrently with the IPO, the company completed a private placement of 187,500 units that raised an additional $1.875 million…

Continue Reading

ThursdayJul 02, 2026 10:21 am

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program 

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ("BiTAC-TCE") program through a collaboration with ATUM, which will apply its Leap-In Transposase(R) technology to generate stable clonal cell lines supporting IND/CTA-enabling activities and future clinical development. The collaboration follows encouraging preclinical data presented at the 2026 American Association for Cancer Research ("AACR") Annual Meeting and is intended to support CMC development, including early process, analytical and formulation development, as well as the production of material for nonclinical studies. VERAXA said its BiTAC-TCE platform is designed to improve tumor selectivity by splitting the T-cell engager into…

Continue Reading

ThursdayJul 02, 2026 9:25 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured in AINewsWire Editorial on U.S. Semiconductor Manufacturing Shift

Nightfood Holdings (OTCQB: NGTF) announced its inclusion in an editorial published by AINewsWire examining how the expansion of U.S. semiconductor manufacturing is creating new opportunities for suppliers and automation companies. The article highlights the company's TechForce Robotics division and its strategic alliance with Taiwan-based Jiun Jiang Enterprise Co. Ltd. (JJ Enterprise), noting the collaboration provides access to semiconductor manufacturing expertise and advanced production capabilities as global chip production increasingly shifts to North America. To view the full press release, visit https://ibn.fm/slPCe About Nightfood Holdings, Inc. / TechForce Robotics Nightfood Holdings, Inc. (OTCQB: NGTF), doing business as TechForce Robotics, is focused…

Continue Reading

WednesdayJul 01, 2026 3:27 pm

QualityStocksNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Targets Untapped Potential of Jameson Land Basin

Greenland Energy (NASDAQ: GLND) is advancing a significant opportunity in Greenland’s Jameson Land Basin, one of the world’s largest remaining underexplored onshore hydrocarbon regions spanning more than 8,400 square kilometers. Under an agreement with 80 Mile, Greenland Energy will fully fund a two-well drilling program planned for the second half of 2026, earning a 70% interest in the project while 80 Mile retains 30%. The basin has attracted decades of industry attention and substantial historical investment due to its potential resource scale. GLND has engaged Halliburton to provide consulting services, logistics planning, and operational support, while additional agreements with Stampede Drilling…

Continue Reading

WednesdayJul 01, 2026 2:09 pm

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Developing Solutions for an Era of Increasing GPS Interference

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) is developing GPS-free navigation and target acquisition technology designed to operate in Denied, Degraded, Intermittent, and Limited (“DDIL”) environments, addressing a growing challenge highlighted in a recent article. The piece examines how GPS jamming has become increasingly common in modern warfare, disrupting navigation, communications, drone operations and precision targeting while also affecting civilian aviation, shipping and transportation networks. As reliance on GPS exposes both military and commercial systems to interference, SPARC AI’s software-only platform leverages artificial intelligence, advanced mathematics and edge…

Continue Reading

WednesdayJul 01, 2026 12:00 pm

The Next Battle in Space Isn’t Launching Satellites. It’s Managing Them.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising. SpaceX's record June 2026 IPO put a public spotlight on space, yet most of the sector's frontier companies remain private and out of reach for public investors Antaris, a software-defined space infrastructure company backed by Planet Ventures, signed a memorandum of agreement with Transcelestial to develop and flight-test a combined surveillance and optical-communications architecture on its JANUS-2 mission in late 2026 Planet Ventures gives public-market investors exposure to private space companies such as Antaris, Relativity Space, and General Astronautics that are typically accessible only…

Continue Reading

WednesdayJul 01, 2026 11:15 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Advances Santa Fe, Walker Lane amid Tightening Gold Supply Dynamics

Disseminated on behalf of  Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Top gold-producing countries are showing strain of widespread government, cost and environmental pressures. These pressures strengthen the case for secure, transparent and infrastructure-supported gold development in the United States. Existing mine infrastructure, historical production, oxide material and location in a leading U.S. gold state may give Lahontan’s Santa Fe project a different development profile. Global gold supply is entering a more complicated era, shaped not only by geology and discovery rates but also by government policy, rising operating costs, safety enforcement, environmental oversight and growing…

Continue Reading

WednesdayJul 01, 2026 10:40 am

Why VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals

Deal activity remains strong in antibody-drug conjugates (ADCs) and T-cell engager (TCE) therapeutics, with pharmaceutical companies continuing to commit substantial capital to preclinical and early-stage innovation. The Jazz Pharmaceuticals–AbCellera collaboration illustrates how differentiated antibody technologies can command significant financial commitments before entering clinical development. VERAXA Biotech AG is positioning its technology platform across both ADCs and T-cell engagers, two therapeutic modalities that continue to attract strategic partnerships and acquisitions. Platform technologies and individual drug candidates both represent potential avenues for future partnering, licensing, and collaboration agreements. Recent transactions across the sector demonstrate that pharmaceutical companies are actively seeking access to…

Continue Reading

WednesdayJul 01, 2026 10:30 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Delivers First Edge AI Intoxication Detection Kiosk Prototypes

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio kiosks use artificial intelligence and voice analysis to detect potential intoxication and fatigue in workplace environments. The company is targeting industries such as mining, aviation, construction, transportation, and law enforcement, where safety-sensitive operations require large-scale screening. MindBio’s AI models have been trained on more than 50 million data points and analyze over 140 acoustic markers associated with impairment. Prototype kiosks are entering testing, validation, and data-analysis phases, before broader commercial deployment. The company is positioning this important new technology as a faster and…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered